PTPI Petros Pharmaceuticals, Inc.
Healthcare$0.01+0.00%ClosedMarket Cap: $190,077
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.16
P/S
0.00
EV/EBITDA
1.23
DCF Value
$18.30
FCF Yield
-3133.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
0.4%
ROA
72.5%
ROIC
-237.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-1.0M | $-987.0K | $— | — |
| Q4 null | $0.00 | NaN% | $-391.5K | $-336.5K | $— | — |
| FY null | $0.00 | NaN% | $-4.6M | $1.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-990.7K | $-922.7K | $— | — |
| Q2 null | $0.00 | NaN% | $-1.8M | $5.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.5M | $-2.3M | $— | — |
| Q4 null | $725.4K | 63.5% | $-9.1M | $-9.3M | $— | — |
| FY null | $5.1M | 76.3% | $-17.7M | $-14.3M | $— | — |
| Q3 null | $1.6M | 81.8% | $-2.3M | $-2.2M | $— | — |
| Q2 null | $1.4M | 76.8% | $-2.3M | $-662.0K | $— | — |
| Q1 null | $1.4M | 24.4% | $-3.9M | $-2.2M | $— | — |
| Q4 2023 | $-364.3K | 143.4% | $-5.0M | $318.1K | $-2.10 | — |